title: The interferon-inducible 9-27 gene modulates the susceptibility to natural killer cells and the invasiveness of gastric cancer cells.
abstract: As an effort to identify immune suppressive molecules in gastric cancer cells, a signal sequence trap was employed. Among the genes identified, 9-27 gene was highly expressed in gastric tumor tissues and in cancer cell lines. It was induced by IFN-gamma treatment, but not by TNF-alpha or TGF-beta1 treatment. The overexpression of 9-27 in the gastric cancer cells rendered tumor cells more resistant to natural killer cells. In addition, the 9-27-overexpressed cells showed an increased migration and an invasive capacity when compared with the control cells. Taken together, these data indicate that 9-27 plays a role in malignant progression by suppressing natural killer cells and by increasing the invasive potential of gastric cancer cells.
authors.affiliation: Laboratory of Immunology, Korea Research Institute of Bioscience and Biotechnology, Eoun-Dong 52, Yusong, Taejon 305-333, South Korea.
authors.forename: Young
authors.initials: Y
authors.lastname: Yang
authors.forename: Jeong-Hyung
authors.initials: JH
authors.lastname: Lee
authors.forename: Kun Yong
authors.initials: KY
authors.lastname: Kim
authors.forename: Hyun Keun
authors.initials: HK
authors.lastname: Song
authors.forename: Jae Kwang
authors.initials: JK
authors.lastname: Kim
authors.forename: Suk Ran
authors.initials: SR
authors.lastname: Yoon
authors.forename: Daeho
authors.initials: D
authors.lastname: Cho
authors.forename: Kyu Sang
authors.initials: KS
authors.lastname: Song
authors.forename: Young Ho
authors.initials: YH
authors.lastname: Lee
authors.forename: Inpyo
authors.initials: I
authors.lastname: Choi
mesh_terms: D000230:Adenocarcinoma / Q000276:immunology / Q000628:therapy; D000943:Antigens, Differentiation; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002465:Cell Movement / Q000187:drug effects*; D020869:Gene Expression Profiling; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000187:drug effects*; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D009361:Neoplasm Invasiveness / Q000473:pathology*; D013274:Stomach Neoplasms / Q000276:immunology* / Q000628:therapy; D016212:Transforming Growth Factor beta / Q000494:pharmacology; D053773:Transforming Growth Factor beta1; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D000943:Antigens, Differentiation; D000970:Antineoplastic Agents; D008565:Membrane Proteins; C508960:TGFB1 protein, human; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D014409:Tumor Necrosis Factor-alpha; C062010:leu-13 antigen; D007371:Interferon-gamma